BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22744872)

  • 1. Three-dimensional power Doppler ultrasound in cervical carcinoma: monitoring treatment response to radiotherapy.
    Huang YF; Cheng YM; Wu YP; Chen HH; Hsu KF; Wu YH; Chou CY
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):84-92. PubMed ID: 22744872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
    Alcazar JL; Arribas S; Martinez-Monge R; Jurado M
    Int J Gynecol Cancer; 2016 Mar; 26(3):534-8. PubMed ID: 26745701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power Doppler angiographic appearance and blood flow velocity waveforms in invasive cervical carcinoma.
    Wu YC; Yuan CC; Hung JH; Chao KC; Yen MS; Ng HT
    Gynecol Oncol; 2000 Nov; 79(2):181-6. PubMed ID: 11063641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma.
    Testa AC; Ferrandina G; Distefano M; Fruscella E; Mansueto D; Basso D; Salutari V; Scambia G
    Ultrasound Obstet Gynecol; 2004 Sep; 24(4):445-52. PubMed ID: 15343602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor vascularization in cervical cancer by 3-dimensional power Doppler angiography: correlation with tumor characteristics.
    Alcázar JL; Jurado M; López-García G
    Int J Gynecol Cancer; 2010 Apr; 20(3):393-7. PubMed ID: 20375803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional power Doppler ultrasound in the early assessment of response to concurrent chemo-radiotherapy for advanced cervical cancer.
    Xu Y; Zhu L; Ru T; Wang H; He J; Zhou Z; Yang X
    Acta Radiol; 2017 Sep; 58(9):1147-1154. PubMed ID: 28068824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional power Doppler ultrasound for the study of cervical cancer and precancerous lesions.
    Belitsos P; Papoutsis D; Rodolakis A; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):576-81. PubMed ID: 22323111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Moro F; Pasciuto T; Moruzzi MC; Di Legge A; Fuoco G; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta A; Miccò M; Rufini V; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):110-118. PubMed ID: 29119649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
    Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A; Weiss E; Hess CF
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D vocal power Doppler sonography for the estimation of tumor volume and vascularization in stage IB1 cervical cancer.
    Daskalakis G; Diamantopoulos D; Theodora M; Semertzidou A; Pappa K; Antsaklis P; Sindos M; Rodolakis A; Kalmantis K
    Arch Gynecol Obstet; 2018 Sep; 298(3):617-622. PubMed ID: 30056504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-stage cervical cancer: agreement between ultrasound and histopathological findings with regard to tumor size and extent of local disease.
    Gaurilcikas A; Vaitkiene D; Cizauskas A; Inciura A; Svedas E; Maciuleviciene R; Di Legge A; Ferrandina G; Testa AC; Valentin L
    Ultrasound Obstet Gynecol; 2011 Dec; 38(6):707-15. PubMed ID: 21538643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cervical volume and spectral Doppler parameters in tumour dominant vessel of patients with locally advanced squamous cell cervical carcinoma.
    Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
    J Obstet Gynaecol; 2021 Oct; 41(7):1116-1120. PubMed ID: 33427547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transvaginal color Doppler ultrasound for monitoring the response to neoadjuvant chemotherapy in advanced cervical cancer.
    Greco P; Cormio G; Vimercati A; Nacci G; di Vagno G; Loverro G; Selvaggi L
    Acta Obstet Gynecol Scand; 1997 Feb; 76(2):169-72. PubMed ID: 9049292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional power Doppler imaging of early-stage cervical cancer.
    Hsu KF; Su JM; Huang SC; Cheng YM; Kang CY; Shen MR; Chang FM; Chou CY
    Ultrasound Obstet Gynecol; 2004 Nov; 24(6):664-71. PubMed ID: 15517537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of external radiotherapy on uterine blood flow in patients with advanced cervical carcinoma assessed by color Doppler ultrasonography.
    Pirhonen JP; Grenman SA; Bredbacka AB; Bahado-Singh RO; Salmi TA
    Cancer; 1995 Jul; 76(1):67-71. PubMed ID: 8630878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doppler Ultrasound Flow Evaluation of the Uterine Arteries Significantly Correlates with Tumor Size in Cervical Cancer Patients.
    Bolla D; In-Albon S; Papadia A; Di Naro E; Gasparri ML; Mueller MM; Raio L
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S959-63. PubMed ID: 26036189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Qin J; Cheng X; Chen X; Zhang X; Lu W; Xie X
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):226-34. PubMed ID: 21845741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.